D.L. Carlson Investment Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-58,545
Closed -$2.94M 159
2021
Q1
$2.94M Buy
58,545
+5,342
+10% +$364K 0.54% 66
2020
Q4
$4.76M Buy
+53,203
New +$4.48M 0.86% 45

Other funds holding CELL

D.L. Carlson Investment Group's CELL Position: Q2 2021 in Review

D.L. Carlson Investment Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2021, closing a stake of 58,545 shares — an estimated $2.94M sold.

D.L. Carlson Investment Group first reported a position in CELL in Q4 2020 and held it in 2 quarters. The position peaked at $4.76M in Q4 2020. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.

  • D.L. Carlson Investment Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 58,545 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $2.94M.
  • D.L. Carlson Investment Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • D.L. Carlson Investment Group's PhenomeX Inc. Common Stock position peaked at $4.76M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2021, filed 12 Aug 2021.